Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCTZachariah DeFilipp,Haesook T. Kim, Laura Knight, Devon Kelley,Michael T. Byrne,Mark A. Schroeder,Roni Tamari,Sarah A. Wall,Sumithira Vasu,Sameem Abedin,Areej R. El-Jawahri,Steven L. McAfee,Yi-Bin Chen,Gabriela HobbsTransplantation and Cellular Therapy(2022)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要